Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Leighton

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of General Physiology|October 30, 2009
QUANTITATIVE STUDIES ON THE PHOTOLETHAL EFFECTS OF QUARTZ ULTRA-VIOLET RADIATION UPON PARAMECIUMA C Giese, P A Leighton
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
The structural H19 gene is required for transgene imprintingK Pfeifer, P A Leighton, S M Tilghman
The British Journal of Dermatology|May 30, 2020
Outcome domains in lichen sclerosusC A Goodrum, P A Leighton, R C Simpson
Biology of Reproduction|February 1, 1996
Genomic imprinting in mice: its function and mechanismP A Leighton, J R Saam, R S Ingram, et al.
Nature|May 4, 1995
Disruption of imprinting caused by deletion of the H19 gene region in miceP A Leighton, R S Ingram, J Eggenschwiler, et al.
Genes & Development|February 12, 1998
Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromesJ Eggenschwiler, T Ludwig, P Fisher, et al.
BMC Public Health|January 24, 2024
Spatial multi-criteria decision analysis for the selection of sentinel regions in tick-borne disease surveillanceC Guillot, C Aenishaenslin, E S Acheson, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
N Increased risk of tick-borne diseases with climate and environmental changesC Bouchard, A Dibernardo, J Koffi, et al.
Genes & Development|September 1, 1995
An enhancer deletion affects both H19 and Igf2 expressionP A Leighton, J R Saam, R S Ingram, et al.
Research Involvement and Engagement|August 28, 2019
Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosisN J Rowbotham, S J Smith, Z C Elliott, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of General Physiology|October 30, 2009
QUANTITATIVE STUDIES ON THE PHOTOLETHAL EFFECTS OF QUARTZ ULTRA-VIOLET RADIATION UPON PARAMECIUMA C Giese, P A Leighton
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
The structural H19 gene is required for transgene imprintingK Pfeifer, P A Leighton, S M Tilghman
The British Journal of Dermatology|May 30, 2020
Outcome domains in lichen sclerosusC A Goodrum, P A Leighton, R C Simpson
Biology of Reproduction|February 1, 1996
Genomic imprinting in mice: its function and mechanismP A Leighton, J R Saam, R S Ingram, et al.
Nature|May 4, 1995
Disruption of imprinting caused by deletion of the H19 gene region in miceP A Leighton, R S Ingram, J Eggenschwiler, et al.
Genes & Development|February 12, 1998
Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromesJ Eggenschwiler, T Ludwig, P Fisher, et al.
BMC Public Health|January 24, 2024
Spatial multi-criteria decision analysis for the selection of sentinel regions in tick-borne disease surveillanceC Guillot, C Aenishaenslin, E S Acheson, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
N Increased risk of tick-borne diseases with climate and environmental changesC Bouchard, A Dibernardo, J Koffi, et al.
Genes & Development|September 1, 1995
An enhancer deletion affects both H19 and Igf2 expressionP A Leighton, J R Saam, R S Ingram, et al.
Research Involvement and Engagement|August 28, 2019
Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosisN J Rowbotham, S J Smith, Z C Elliott, et al.
Pageof 2